Retraction
Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1
Paper Information
Record ID:
55131
Author(s):
Journal:
Publication Date:
March 18, 2021
Retraction Date:
July 15, 2024
(1.3 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/mmr.2024.13291Additional Notes:
see also: https://pubpeer.com/publications/E77BCB5384F2CD019E6EA08A660452
Citations (13)
13
Total Citations1
Post-Retraction(7.7%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
48
Days since retraction (latest)
Modified bone marrow mesenchymal stem cells derived exosomes loaded with <scp>MiRNA</scp> ameliorates non‐small cell lung cancer
Mingjun Yang, Wen Zhou, Xiao Han et al. (8 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Sep 2024
1 citation
1 citation
48 days after retraction
Perspective and Therapeutic Potential of the Noncoding RNA–Connexin Axis
Xinmu Li, Zhen‐Zhen Wang, Nai‐Hong Chen
International Journal of Molecular Sciences
Open Access
Published: Jun 2024
1 citation
1 citation
43 days before retraction
Research progress of the netrins and their receptors in cancer
Xing Gao, Jiazhou Ye, Xi Huang et al. (12 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Mar 2024
4 citations
4 citations
109 days before retraction
Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2024
1 citation
1 citation
152 days before retraction
Tumor Suppressor miR-613 Alleviates Non-Small Cell Lung Cancer Cell via Repressing M2 Macrophage Polarization
Mingjun Yang, Wen Zhou, Mingming Xu et al. (7 authors)
Journal of Oncology
Open Access
Published: Feb 2023
2 citations
2 citations
515 days before retraction
miR-613 suppresses renal cell carcinoma proliferation, invasion and migration by regulating the AXL/AKT pathway
Wanli Duan, Siyuan Pan, Yuyao Zhai et al. (7 authors)
Experimental Biology and Medicine
Open Access
Published: Feb 2023
3 citations
3 citations
530 days before retraction
The Prognostic Significance of miR-613 in Malignant Tumors and Association with Clinical Characteristics: A Systematic Review and Meta-Analysis
Vinh Thanh Tran
Eurasian Journal of Medicine and Oncology
Open Access
Published: Jan 2023
561 days before retraction
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment
Atqiya Fariha, Ithmam Hami, Mahafujul Islam Quadery Tonmoy et al. (8 authors)
Heliyon
Open Access
Published: Oct 2022
15 citations
15 citations
653 days before retraction
Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review)
Ruijie Ma, Chao Ma, Kang Hu et al. (6 authors)
International Journal of Oncology
Open Access
Published: Jul 2022
20 citations
20 citations
733 days before retraction
MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
Maria Konoshenko, Yuriy Lansukhay, Sergey E. Krasilnikov et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Jul 2022
22 citations
22 citations
738 days before retraction
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
Javaid Ahmad Wani, Sabhiya Majid, Zuha Imtiyaz et al. (9 authors)
Diagnostics
Open Access
Published: Jul 2022
28 citations
28 citations
745 days before retraction
Lnc-TMEM132D-AS1 Confers Acquired Resistance to Osimertinib in Non-Small-Cell Lung Cancer
Nan Wang, Qilin Zhao, Yutang Huang et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Jun 2022
759 days before retraction
Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma
Aneta Polewko-Klim, Sibo Zhu, Weicheng Wu et al. (16 authors)
Frontiers in Genetics
Open Access
Published: May 2022
1 citation
1 citation
788 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
1.3 year
Open Access:
Yes
Last Checked:
Jul 24, 2025